The global bioconjugation market is set to witness a growth rate of ~13% in the next 5 years. Increasing demand for targeted ...

On September 25, innovative new drug developer Qurient announced that it has signed a licensing agreement with Synaffix, a subsidiary of Lonza and a ...

There remains a need to closely link high-quality and sensitive disease surveillance with immunisation efforts, as well as monitoring of anti-vaccine narratives ...

This study reports the important finding that the dynamin inhibitor Dyngo-4a broadly affects lipid packing and plasma membrane dynamics, independently of its action on dynamin. While solid ...

Robert Lee's new adaptation of Arthur Schnitzler's 19th century play has 10 characters trading partners and playing games.

The Company plans to present the preclinical data at an upcoming scientific conference. About Akari Therapeutics ...

Preclinical data presented at the 10th Annual CAR-TCR Summit demonstrated deep depletion of B cells in blood and tissue in humanized mouse models and non-human primates, supporting nomination of ...

A $3.5 million philanthropic gift is helping Cleveland-based University Hospitals Seidman Cancer Center triple its clinical trial capacity by 2030 — ...

Bank of America Global Healthcare Conference 2025 September 25, 2025 6:35 AM EDTCompany ParticipantsOlivier Loeillot ...

In a new study, Picture Health's QVT score identified responders and non-responders to immunotherapy and chemoimmunotherapy.

Rapid release testing detects mycoplasma DNA with great sensitivity by using advanced technologies such nucleic acid ...

The Helicobacter pylori (H. pylori) infection market is segmented by therapies, with key approved products including TALICIA ...